Invasive Pulmonary Aspergillosis
Invasive pulmonary aspergillosis is growing in incidence, as patients at risk are growing in diversity. Outside the classical context of neutropenia, new risk factors are emerging or newly identified, such as new anticancer drugs, viral pneumonias and ...
Marie-Pierre Ledoux, Raoul Herbrecht
doaj +4 more sources
Clinical Features and Predictive Risk Factors for Prognosis in Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis. [PDF]
PM patients exhibit distinctions from IPA in certain clinical characteristics, laboratory parameters, and chest radiology findings. Nevertheless, both PM and IPA patients experienced higher 30‐day mortality and ICU utilization. The combination of NLR and HbA1c with existing disease assessment tools proves effective in prognosticating the disease ...
Bai Y +5 more
europepmc +2 more sources
A Case Report of Immune Checkpoint Inhibitor-Associated Pneumonia Complicated by Invasive Pulmonary Aspergillosis in a Patient With Chronic Obstructive Pulmonary Disease. [PDF]
ABSTRACT This case reports a patient with chronic obstructive pulmonary disease who developed immune checkpoint inhibitor‐associated pneumonia following immunotherapy, complicated by invasive pulmonary aspergillosis. Such cases are rare and pose diagnostic challenges in clinical practice. The successful diagnosis and treatment of this patient provide a
Lin S.
europepmc +2 more sources
Subacute invasive pulmonary aspergillosis
Subacute invasive pulmonary aspergillosis (IPA) is an indolent cavitating infectious process which can mimic other chronic lung infections such as tuberculosis.
Ravindran Chetambath
doaj +2 more sources
Fulminant invasive aspergillosis of the mediastinum in an immunocompetent host: a case report [PDF]
Introduction Invasive aspergillosis is a serious complication in immunocompromised patients. It is an opportunistic disease, which predominantly occurs in the lungs, although dissemination to virtually any organ is possible.
Shakoor Muhammad +3 more
doaj +3 more sources
Co-infection of active pulmonary tuberculosis and invasive pulmonary aspergillosis following a liver transplant: a case report [PDF]
Background We report a rare case of co-infection involving pulmonary tuberculosis and invasive aspergillosis following a liver transplant. Case presentation A 25-year-old female housewife immigrant from Afghanistan, who had autoimmune hepatitis and ...
Sara Abolghasemi +4 more
doaj +2 more sources
Invasive pulmonary aspergillosis [PDF]
AbstractInvasive pulmonary aspergillosis (IPA) remains difficult to diagnose and to treat. Most common risk factors are prolonged neutropenia, hematopoietic stem cell or solid organ transplantation, inherited or acquired immunodeficiency, administration of steroids or other immunosuppressive agents including monoclonal antibodies and new small ...
L A, Fernández-Bermejo +1 more
+10 more sources
Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]
Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed +7 more
doaj +1 more source
Clinical periodontal diagnosis
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
Invasive pulmonary aspergillosis is associated with high mortality. For diagnosis, galactomannan-antigen in serum and bronchoalveolar lavage fluid is recommended, with higher sensitivity in bronchoalveolar lavage fluid.
Kathrin Rothe +6 more
doaj +1 more source

